`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`ELI LILLY AND COMPANY
`Petitioner
`
`v.
`
`TEVA PHARMACEUTICALS INTERNATIONAL GMBH
`Patent Owner
`
`_____________________
`
`Case IPR2018-01425
`U.S. Pat. No. 9,890,210
`_____________________
`
`TEVA PHARMACEUTICALS INTERNATIONAL
`GMBH’S UPDATED MANDATORY NOTICES
`
`
`
`
`
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`Patent Owner, Teva Pharmaceuticals International GmbH, hereby files
`
`IPR2018-01425
`U.S. Patent No. 9,890,210
`
`updated mandatory notices pursuant to 37 C.F.R. § 42.8(a)(2) in order to provide
`
`information regarding new related matters.
`
`A. Related Matters (37 C.F.R. § 42.8(b)(2))
`
` Patent Owner notes the following new judicial matters that may affect or be
`
`affected by a decision in this proceeding:
`
`• Teva Pharmaceuticals International GmbH v. Eli Lilly and Company,
`
`Civ. No. 1-18-cv-12029 (D. Mass.);
`
`• Eli Lilly and Company v. Teva Pharmaceuticals International GmbH
`
`IPR2018-01710;
`
`• Eli Lilly and Company v. Teva Pharmaceuticals International GmbH
`
`IPR2018-01711; and
`
`• Eli Lilly and Company v. Teva Pharmaceuticals International GmbH
`
`IPR2018-01712.
`
`
`
`
`
`
`
`IPR2018-01425
`U.S. Patent No. 9,890,210
`The Patent Trial and Appeal Board is hereby authorized to charge any fees
`
`associated with this proceeding to Deposit Account 19-0036 (Customer ID
`
`No. 45324).
`
` Respectfully Submitted,
` STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`
`
`
` Deborah Sterling, Ph.D.
`Date: October 19, 2018
` Lead Attorney for Patent Owner
`
`
`
`
`
`1100 New York Avenue, N.W. Registration No. 62,732
`Washington, D.C. 20005-3934
`(202) 371-2600
`
`
`
`
`
`CERTIFICATE OF SERVICE (37 C.F.R. § 42.6(e))
`
`
`
`The undersigned hereby certifies that the above-captioned “Teva
`
`Pharmaceuticals International GmbH’s Updated Mandatory Notices” was served in
`
`its entirety on October 19, 2018, upon the Petitioner via e-mail:
`
`Sanjay M. Jivraj
`Mark J. Stewart
`Eli Lilly and Company
`Lilly Corporate Center Patent Dept.
`Indianapolis, IN 46285
`jivraj_sanjay@lilly.com
`stewart_mark@lilly.com
`
`William B. Raich
`Erin M. Sommers
`Pier D. DeRoo
`Yieyie Yang
`Finnegan, Henderson, Farabow,
`Garrett & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001
`william.raich@finnegan.com
`erin.sommers@finnegan.com
`pier.deroo@finnegan.com
`yieyie.yang@finnegan.com
`
`
`
`
` STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`
`
`
` Deborah Sterling, Ph.D.
`Date: October 19, 2018
` Lead Attorney for Patent Owner
`
`
`
`
`
`1100 New York Avenue, N.W. Registration No. 62,732
`Washington, D.C. 20005-3934
`(202) 371-2600
`
`10212697.1
`
`